Former US FDA orphan drugs head joins National Organization for Rare Disorders
This article was originally published in SRA
Executive Summary
Timothy R Coté has been appointed chief medical officer of the National Organization for Rare Disorders in the US, having served as director of the Food and Drug Administration's Office of Orphan Products Development between 2007 and May 2011. Dr Coté's new role will be to provide medical guidance in all areas – particularly advocacy and education – to promote fair, compassionate public policies; encourage the development of safe, effective treatments; and increase awareness of rare diseases and the needs of patients and their families.